Sweeping US sanctions bill offers Ukraine new leverage on Russia, but enforcement looms

The bill aims to cut off financial resources President Vladimir Putin relies on; its impact depends on how aggressively the U.S. implements it.
READ NEXT
More on the wire
FROM THE PUBLISHER
To get drugs and devices out faster, the FDA lets companies conduct studies of safety or efficacy after the products are approved. In many cases, such “postmarket” studies are behind schedule or overdue.
FROM THE PUBLISHER
Groups aligned with President Trump’s $400 million Maga Inc. super PAC have also turned their attention toward the contest.
FROM THE PUBLISHER
Americans now have just over six weeks to decide whether they want the House and Senate to remain in Republican control or flip to Democrats.